Quanta Announces IND Clearance by U.S. FDA for QTX3544, an Oral G12V-Preferring Multi-KRAS Inhibitor, and Other Pipeline Updates
Additionally, the Phase 1 clinical trial evaluating QTX3034, an oral G12D-preferring multi-KRAS inhibitor, as a monotherapy and in combination with cetuximab, continues to enroll patients, and data is ...
Le Lézard42m
Mytos Announces Manufacturing Collaboration with Aspen Neuroscience in Parkinson's Disease
Mytos, an innovative leader in automated cell manufacturing, has entered into a manufacturing collaboration with Aspen Neuroscience, Inc. to automate the manufacturing of autologous dopaminergic ...
Le Lézard34m
Viralgen partners with Vallabh/Minikel Lab and Deverman Lab at the Broad Institute to advance gene therapy manufacturing hope for prion disease
Viralgen and two labs based in the Broad Institute of MIT (Massachusetts Institute of Technology) and Harvard University have partnered to develop and manufacture an innovative approach to gene ...
AMD is going head-to-head with Nvidia in AI-backed drug discovery with new deal
Chip maker AMD is investing $20 million in AI drug startup Absci, which will use AMD chips and software for drug development.